Use of GLP-1 receptor agonists to treat type 2 diabetes is not associated with an increased risk of suicidality compared with ...

Evidence suggests no increased risk The use of glucagon-like peptide-1 (GLP-1) receptor agonists has surged in recent years, driven by their benefits in glucose control in type 2 diabetes, weight ...

People with a high body weight living in England can now access subsidised weight-loss drugs to treat their obesity.

Eli Lilly and Company said Wednesday they plan to build new pharmaceutical manufacturing sites in the United States.

“The thing most amazing about them is how these drugs suddenly alter the dopamine-related reward pathway in the brain making us less of a slave to cravings. Today, 73% of Americans are obese or ...

On his Instagram profile, the “Queer Eye” star Jonathan Van Ness detailed that he lost 30 kg with GLP-1 weight-loss ...

Bloating always seems to come at the most inconvenient times - before a wedding, a big presentation at work, a Pilates class, ...